The crucial acquisition would make CPH the only ASX-listed medicinal cannabis company with direct exposure to the Colombian market — representing a key step in its efforts to penetrate Latin America's medicinal cannabis market now including Argentina, Colombia, Chile, Mexico and Uruguay.
read more here
Delivered by @can_nab_is
No comments:
Post a Comment